# Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

> **NCT06061926** · PHASE2 · RECRUITING · sponsor: **University of Guadalajara** · enrollment: 28 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Celery Seed
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06061926
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-20
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061926, "Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06061926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*